Effect of Fetal Pituitary-Testes Suppression on Brain Sexual Differentiation and Reproductive Function in Male Sheep
Endocrinology · 2023
DOI: 10.1210/endocr/bqad129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, 2023. Verfasst von Rebecka Amodei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, OR 97239-3098, USA. Hauptthemen laut MEDLINE: Testis, Pituitary Diseases. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, grants, Endocrine Technologies Support Core.
Abstract (Originalsprache)
We previously demonstrated that treating fetal lambs on gestational day 62 with the long-acting gonadotrophin-releasing hormone (GnRH) antagonist degarelix (DG) suppresses pituitary-testicular function during midgestation. The objective of this study was to investigate whether impaired gonadotrophic drive during this fetal period has enduring effects on sexual differentiation and reproductive function in adult male sheep. We assessed the effects of prenatal administration of DG, with or without testosterone (T) replacement, on various sexually dimorphic behavioral traits in adult rams, including sexual partner preferences, as well as neuroendocrine responsiveness and testicular function. Our findings revealed that DG treatment had no effect on genital differentiation or somatic growth. There were some indications that DG treatment suppressed juvenile play behavior and adult sexual motivation; however, male-typical sexual differentiation of reproductive behavior, sexual partner preference, and gonadotropin feedback remained unaffected and appeared to be fully masculinized and defeminized. DG-treated rams showed an increased LH response to GnRH stimulation and a decreased T response to human chorionic gonadotropin stimulation, suggesting impaired Leydig cell function and reduced T feedback. Both effects were reversed by cotreatment with T propionate. DG treatment also suppressed the expression of CYP17 messenger RNA, a key enzyme for T biosynthesis. Despite the mild hypogonadism induced by DG treatment, ejaculate volume, sperm motility, and sperm morphology were not affected. In summary, these results suggest that blocking GnRH during midgestation does not have enduring effects on brain sexual differentiation but does negatively affect the testes' capacity to synthesize T.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, OR 97239-3098, USA.
- Center for Developmental Health, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR 97239-3098, USA.
- Department of Animal and Rangeland Sciences, Oregon State University, Corvallis, OR 97331-4501, USA.
- College of Veterinary Medicine, Oregon State University, Corvallis, OR 97331-4501, USA.
ORCID-Profile: Charles E Roselli
Förderung
- NIH HHS
- grants
- Endocrine Technologies Support Core
- Oregon National Primate Research Center
Zitieren
APA
Amodei, R., Jonker, S. S., Smallman, M., Whitler, W., Estill, C. T., & Roselli, C. E. (2023). Effect of Fetal Pituitary-Testes Suppression on Brain Sexual Differentiation and Reproductive Function in Male Sheep. Endocrinology. https://doi.org/10.1210/endocr/bqad129
Vancouver
Amodei R, Jonker SS, Smallman M, Whitler W, Estill CT, Roselli CE. Effect of Fetal Pituitary-Testes Suppression on Brain Sexual Differentiation and Reproductive Function in Male Sheep. Endocrinology. 2023. doi:10.1210/endocr/bqad129
BibTeX
@article{Amodei2023,
author = {Amodei, Rebecka and Jonker, Sonnet S and Smallman, Mary and Whitler, William and Estill, Charles T and Roselli, Charles E},
title = {Effect of Fetal Pituitary-Testes Suppression on Brain Sexual Differentiation and Reproductive Function in Male Sheep},
journal = {Endocrinology},
year = {2023},
doi = {10.1210/endocr/bqad129}
}
EUVIMED